08:00 , Dec 4, 2000 |  BC Week In Review  |  Company News

Akkadix, Research Seeds Inc., The Samuel Roberts Noble Foundation deal

The parties will participate in research sponsored in part by Research Seeds subsidiary Forage Genetics Inc. (West Salem, Wis.) to improve the quality and digestability of forage crops, including alfalfa. Akkadix will provide research support...
07:00 , Sep 18, 2000 |  BC Week In Review  |  Company News

Akkadix, Pangene deal

Akkadix received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) technology for DNA modification and rearrangement in plant science applications, and received a non-exclusive license for DNA cloning. Pangene received a non-exclusive cross-license to...
07:00 , Sep 14, 2000 |  BC Extra  |  Company News

Akkadix licensing deal with Pangene

Akkadix (La Jolla, Calif.) received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) platform for homology-based DNA modification and rearrangement for use in plant science applications. Akkadix also received a non-exclusive license to the...
08:00 , Mar 13, 2000 |  BC Week In Review  |  Company News

Akkadix, University of Edinburgh deal

The parties expanded and extended their 1999 research agreement under which the university will begin a discovery program using a targeted activation tagging approach to identify genes controlling important agriculture traits. Akkadix will provide three...
08:00 , Feb 22, 2000 |  BC Extra  |  Financial News

Bay City Capital closes NANAF

Bay City closed its $145 million North American Nutrition and Agribusiness Fund (NANAF), which invests in the nutrition and agribusiness sectors in North America. Limited partners in the fund include Novartis Agribusiness Biotechnology Research; General...
08:00 , Dec 6, 1999 |  BC Week In Review  |  Company News

Akkadix management update

(Acquisition, B3) Akkadix Corp., San Diego, Calif.   Business: Agbio/Veterinary/Environmental   Hired: Gary Duncan as president of Akkadix's Akkadix Genetics Inc. subsidiary, formerly managing partner at Rio Grande Technologies   ...
07:00 , Oct 25, 1999 |  BC Week In Review  |  Company News

Akkadix other research news

Akkadix received an $800,000 Phase II SBIR grant from the National Institute for General Medical Sciences to develop an automated software-based method of determining protein function. Akkadix Corp., San Diego, Calif.   Product: High throughput protein...
07:00 , Sep 13, 1999 |  BC Week In Review  |  Company News

Akkadix management update

(Merger completed, B4) Akkadix Corp., San Diego, Calif.   Business: Agbio/Veterinary/Environmental   Hired: Jerry Caulder as chairman and CEO, formerly chairman and CEO of Xyris Corp.; and Gary Richardson as president and COO, formerly president of...
07:00 , Sep 13, 1999 |  BC Week In Review  |  Company News

Xyris, Global Agro Inc. deal

The companies completed their stock merger to become Akkadix Corp. (see BioCentury, April 26). (Management, B6) Xyris Corp., San Diego, Calif.   Global Agro Inc., San Diego, Calif.   Business: Agbio/Veterinary/Environmental   ...
07:00 , Aug 2, 1999 |  BioCentury  |  Strategy

Axys: Selective disacquisition

Axys Pharmaceuticals Inc. - then Arris Pharmaceutical Corp. - acquired toolkit company Sequana Therapeutics Inc. in 1997 for $166 million in stock, a price many investors at the time fretted was too high (see BioCentury...